Komori
Monthly4880CellSource Co.,Ltd.Pharmaceuticals

March Monthly KPI Flash Report for the Fiscal Year Ending October 2026

The average daily number of contracted processing cases in March was 55.4, a slight decrease from the same month last year. By medical specialty, cases for orthopedic clinics specializing in private-pay treatment declined, while cases for hybrid-type orthopedic clinics and obstetrics and gynecology clinics increased.

Worth reading
72In focus
Scored from 3 of 5 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
55.4
Appointments/day
Wording
Conditional
How definitive the wording is.

Sales for this month

March 2026Fiscal year ending October 2026
Monthly Commentary

The average daily number of contracted processing cases in March decreased slightly from the same month last year to 55.4. By medical specialty, cases for orthopedic clinics specializing in private-pay treatment declined, while cases for hybrid-type orthopedic clinics and obstetrics and gynecology clinics increased. Cases for aesthetic medicine were unchanged.

Factors Affecting the Change

Organizational strengthening through the management support business for medical corporations, Enhanced support to promote usage of the hybrid-type orthopedic service, Impact of orders being brought forward as a result of the October initiatives, Strategy in Group 2 based on the KPI revised at the beginning of the current fiscal year

Measures from the following month onward

For hybrid-type orthopedic clinics, the Company aims to build up order volumes over the medium to long term. In Group 1, the Company will deploy sales resources to steadily increase order volumes, while in Group 2, it aims to expand order volumes by supporting the launch of newly affiliated clinics and promoting usage.

Sales for this month
ItemDetails
Month CoveredMarch 2026
Fiscal Year CoveredFiscal year ending October 2026
Year-on-year change by categoryName Self-pay orthopedic clinics / Year on year Down 18.7%, Name Hybrid orthopedic clinics / Year on year Up 13.2%, Name Obstetrics and gynecology clinics / Year on year Up 3.9% year on year, Name Cosmetic medicine / Year on year Unchanged, Name Hybrid-type medical institutions, Group 1 / Year on year Down 132 cases (down 0.4 cases per clinic), Name Hybrid-type medical institutions, Group 2 / Year on year Up 426 cases (up 0.3 cases per clinic)
Key KPIsIndicator name Average number of processing orders accepted per day / Value 55.4 Appointments/day / Year on year Slight decrease, Indicator name Number of blood-derived processing orders accepted from self-pay orthopedic clinics / Value 710 Engagements / Year on year Down 18.7%, Indicator name Number of blood-derived processing orders accepted from hybrid orthopedic clinics / Value 791 Engagements / Year on year Up 13.2%, Indicator name Number of orders from hybrid medical institutions / Value 3,477 Engagements / Year on year Increased compared with the same period of the previous year
Monthly CommentaryThe average daily number of contracted processing cases in March decreased slightly from the same month last year to 55.4. By medical specialty, cases for orthopedic clinics specializing in private-pay treatment declined, while cases for hybrid-type orthopedic clinics and obstetrics and gynecology clinics increased. Cases for aesthetic medicine were unchanged.
Factors Affecting the ChangeOrganizational strengthening through the management support business for medical corporations, Enhanced support to promote usage of the hybrid-type orthopedic service, Impact of orders being brought forward as a result of the October initiatives, Strategy in Group 2 based on the KPI revised at the beginning of the current fiscal year
Measures from the following month onwardFor hybrid-type orthopedic clinics, the Company aims to build up order volumes over the medium to long term. In Group 1, the Company will deploy sales resources to steadily increase order volumes, while in Group 2, it aims to expand order volumes by supporting the launch of newly affiliated clinics and promoting usage.
Items this document does not state (15)
Scope of aggregationNet sales for the monthYear-on-year change in monthly net salesTotal-store sales, year on yearSame-Store Sales, Year on YearYear-on-Year Change in Customer CountYear-on-Year Change in Average Spend per CustomerCumulative Sales from Start of PeriodCumulative Year-on-Year Change from Start of PeriodSales by categoryNumber of Stores at Period-EndNumber of stores opened during the monthNumber of stores closed during the monthMonthly trend for the same period last yearNext Scheduled Disclosure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Although organizational strengthening through the management support business for medical corporations continued, cases for orthopedic clinics specializing in private-pay treatment declined year on year. Enhanced support to promote usage of the hybrid-type orthopedic service produced results. For orders from hybrid-type medical institutions, the strategy based on the KPI revised at the beginning of the current fiscal year contributed to results in Group 2, while in Group 1, the impact of orders being brought forward as a result of the October initiatives was reflected in the year-on-year comparison.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
March Monthly KPI Flash Report for the Fiscal Year Ending October 2026 | CellSource Co.,Ltd. (4880) timely disclosure | Komori